See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
6
1
$6.92M
$0.00
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Jul 22, 2026 RA CAPITAL MANAGEMENT, L.P. |
RA CAPITAL MANAGEMENT, L.P.
|
Buy |
47,250 | $29.77 | 47,250 $29.77 $1,406,633 |
Jul 21, 2026 RA CAPITAL MANAGEMENT, L.P. |
RA CAPITAL MANAGEMENT, L.P.
|
Buy |
21,696 | $27.96 | 21,696 $27.96 $606,620 |
Jul 21, 2026 RA CAPITAL MANAGEMENT, L.P. |
RA CAPITAL MANAGEMENT, L.P.
|
Buy |
6,504 | $29.17 | 6,504 $29.17 $189,722 |
Jul 21, 2026 RA CAPITAL MANAGEMENT, L.P. |
RA CAPITAL MANAGEMENT, L.P.
|
Buy |
37,723 | $30.00 | 37,723 $30.00 $1,131,690 |
Jul 20, 2026 RA CAPITAL MANAGEMENT, L.P. |
RA CAPITAL MANAGEMENT, L.P.
|
Buy |
98,433 | $27.13 | 98,433 $27.13 $2,670,487 |
Jul 20, 2026 RA CAPITAL MANAGEMENT, L.P. |
RA CAPITAL MANAGEMENT, L.P.
|
Buy |
32,987 | $27.72 | 32,987 $27.72 $914,400 |
Jun 15, 2026 SEBULSKY ALAN |
SEBULSKY ALAN
|
Buy |
5,000 | $26.00 | 5,000 $26.00 $129,989 |
Jun 15, 2026 SEBULSKY ALAN |
SEBULSKY ALAN
|
Buy |
4,065 | $27.10 | 4,065 $27.10 $110,146 |
Jun 12, 2026 SEBULSKY ALAN |
SEBULSKY ALAN
|
Buy |
8,435 | $27.67 | 8,435 $27.67 $233,393 |
Jun 11, 2026 RA CAPITAL MANAGEMENT, L.P. |
RA CAPITAL MANAGEMENT, L.P.
|
Buy |
19,728,353 | $20.00 | 19,728,353 $20.00 $394,567,060 |
Jun 11, 2026 RA CAPITAL MANAGEMENT, L.P. |
RA CAPITAL MANAGEMENT, L.P.
|
Buy |
1,460,397 | $20.00 | 1,460,397 $20.00 $29,207,940 |
Jun 11, 2026 Levy Guy |
Levy Guy
|
Buy |
125,000 | $20.00 | 125,000 $20.00 $2,500,000 |
Jun 11, 2026 Levy Guy |
Levy Guy
|
Buy |
375,000 | $20.00 | 375,000 $20.00 $7,500,000 |
Jun 11, 2026 SEBULSKY ALAN |
SEBULSKY ALAN
|
Buy |
12,500 | $20.00 | 12,500 $20.00 $250,000 |
View older insider trading records reported to the SEC to research long-term buying and selling trends.
No Historical Insider Transactions found for Parabilis Medicines, Inc.
TOP